Multicenter Validation of a Risk Prediction Model for MDRGNB Infection

ConditionInfection
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorThe Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School

About this trial

This prospective multicenter validation study aimed to evaluate the predictive performance of a previously developed model for MDRGNB infection in ICU patients.

Eligibility criteria

Qualifiers

Age ≥18 years;

ICU stay ≥48 hours;

At least one clinical microbiological specimen collected and submitted for testing within 48 hours of ICU admission, with the first submission time designated as the index time;

Core predictive variables of the model extractable from electronic medical records or laboratory information systems.

Disqualifiers

For patients with multiple ICU admissions, only the first ICU stay was retained;

Missing or indeterminate primary outcome;

Missing key predictive variables that could not be handled according to prespecified rules.

Trial design

Treatments tested in this trial

  • Not listed

Trial groups

1,000 Participants
are grouped into 1 trial group

Locations

11
Nanjing Drum Tower Hospital210008, NanjingJiangsu, China
Ankang People's Hospital Ankang China
Sinopharm Tongmei General Hospital Datong China
First Affiliated Hospital of Gannan Medical University Ganzhou China

Sponsors and collaborators

The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School

Lead sponsor

Ruijin Hospital

Collaborator

Zhejiang Hospital

Collaborator